Status:
COMPLETED
Longitudinal and Cross-sectional Analysis of Pulmonary Microbiota in Lung Transplant Recipients Infected With Nocardia
Lead Sponsor:
Zhibin Xu
Conditions:
Nocardia Infections
Lung Transplantation
Eligibility:
All Genders
18+ years
Brief Summary
This retrospective observational study aims to explore the impact of Nocardia infection on the pulmonary microbiota of lung transplant recipients (LTRs). The study will analyze both cross-sectional an...
Detailed Description
This study is a single-center, retrospective, observational study designed to investigate the impact of Nocardia infection on the pulmonary microbiota of lung transplant recipients (LTRs). The study w...
Eligibility Criteria
Inclusion
- Lung transplant recipients
- Diagnosed with Nocardia pneumonia (for the study group)
- Age ≥ 18 years
Exclusion
- Patients with incomplete medical records
- Patients who survived ≤ 3 days after transplantation
- Patients lost to follow-up
Key Trial Info
Start Date :
January 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2024
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT06594133
Start Date
January 1 2023
End Date
September 1 2024
Last Update
November 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangzhou Institute of Respiratory Diseases, the First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China, 510120